Sionna Therapeutics, Inc. (SION)
NASDAQ · Manufacturing · Pharmaceutical preparations
$5.23−$0.0018 (−0.03%) on the dayAs of the close; data may be delayed.
SION price, last 12 months
Key stats
- Previous close
- $5.23
- Open
- $5.37
- Day range
- $5.09 – $5.37
- 52-week range
- $4.01 – $54.97
- Volume
- 1.2M
- Avg volume (20 days)
- 1.5M
- Market cap
- $236.5M
Performance
1W−12.3%
1M−15.3%
3M−87.6%
6M−86.2%
YTD−87.3%
1Y−80.7%
vs S&P 500, 1Y−97.5 pts
Technicals and fundamentals
About Sionna Therapeutics, Inc.
Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefits to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $236.5M